STAT

Opinion: Why does my health insurer sabotage my efforts to manage my diabetes?

It makes no sense that health insurance will quickly cover kidney dialysis or an amputation for people with type 1 diabetes but they must fight for the things that will…
Source: Reed Saxon/AP

In a raw crypt beneath Our Lady of the Conception of the Capuchins church in Rome stretches an exuberant display of skeletal remains. The piled skulls, fanned hip bones, and arched spines — remnants of centuries of Capuchin friars — bear a warning. Printed on a sign in three languages, it reads: “What you are now, we once were. What we are now, you shall be.”

I was studying abroad when I faced and promptly buried that grim exhortation in a lemon gelato. I was athletic, healthy, and 21. Surely I would never be them. My body was mine to control.

But two years later, just before my college graduation, odd symptoms began to surface: blurred vision, fatigue, an insatiable thirst. I hoped I might just need glasses, but the diagnosis came

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related